St. Jude Medical Shares Drop on Report of Heart Lead Problem
(Reuters) - Shares of St Jude Medical Inc (STJ.N) fell 6 percent on Tuesday afternoon after a physician reported to U.S. regulators a failure of the company's Durata brand lead wire connecting an implanted defibrillator to the heart in a single patient.
The report, posted in a U.S. Food and Drug Administration database, said the lead conductor became externalized, meaning the wire carrying electricity from the defibrillator to the heart was exposed through its insulation.
The report, posted in a U.S. Food and Drug Administration database, said the lead conductor became externalized, meaning the wire carrying electricity from the defibrillator to the heart was exposed through its insulation.